Founding Partner
Yes, parts of a clinical trial protocol can be protected by copyright, but the protection is limited. Copyright law does not cover the scientific ideas, methods, or procedures themselves, only the original written expression used to describe them. That distinction matters for pharmaceutical companies, research institutions, and sponsors who invest heavily in protocol development. Understanding where protection begins and ends helps you manage risk when protocols are shared, submitted, or reused.
Are Clinical Trial Protocols Protected by Copyright Law?
A clinical trial protocol is typically a detailed written document that outlines study objectives, methodology, eligibility criteria, statistical analysis, and reporting plans. Under U.S. copyright law, written documents are protected as literary works if they include original expression.
That means a protocol may qualify for copyright protection as a document, even though the underlying science does not. The protection attaches automatically when the protocol is created in a fixed form, such as a written or digital file.
What copyright does not protect is just as important. The law draws a firm line between expression and function, especially in technical and scientific contexts.
What Parts of a Clinical Trial Protocol Are Not Copyrightable?
Copyright does not extend to ideas, facts, systems, or methods of operation. Clinical trial protocols are heavily functional, which limits how much of the document can be protected.
Elements that are generally not copyrightable include:
- Study designs, methodologies, and experimental procedures
- Scientific hypotheses or biological mechanisms
- Statistical formulas and data analysis methods
- Regulatory requirements dictated by the FDA or other agencies
Even if these elements are described in your protocol, others are free to use the same concepts as long as they do not copy your original wording.
What Parts of a Protocol Can Be Copyrighted?
While the functional aspects are excluded, original narrative content can still receive protection. This often includes the way information is organized and explained, especially where there is room for author choice.
Potentially protectable elements include:
- Original explanatory text describing study rationale
- Custom background sections or narrative summaries
- Unique structure or sequencing of sections, if not dictated by regulation
- Tables or figures that reflect creative choices, not just raw data
In practice, this means that verbatim copying of substantial portions of a protocol may infringe copyright, even if the copied material relates to a scientific process. Because protocols are highly functional, courts often view any copyright protection as narrow and focused on verbatim or near-verbatim copying.
How Does Copyright Differ From Patent Protection?
It is common to confuse copyright and patent protection in clinical research. They serve different purposes and protect different interests.
Copyright protects the written expression of a protocol, not the invention being studied. A patent, by contrast, may protect a new drug, device, or treatment method if it meets patentability requirements.
You can hold copyright in a protocol even if the underlying invention is not patented, and vice versa. Many organizations rely on a mix of copyright, patent rights, and contractual controls to protect their work.
Risks When Sharing or Submitting Clinical Trial Protocols
Protocols are routinely shared with regulators, collaborators, institutional review boards, and contract research organizations. Submitting a protocol to a regulator does not waive copyright ownership, but it can affect how widely the material is accessed and reused in practice. Each disclosure creates potential exposure.
Common risks include:
- Reuse of protocol language by competitors or collaborators
- Assumptions that regulatory submission waives ownership rights
- Internal confusion about who owns the protocol, especially in sponsored studies
Copyright alone may not stop misuse, but it can support enforcement when copying crosses the line from concept to expression.
Practical Steps to Protect Your Clinical Trial Protocol
Because copyright protection is limited, it works best as part of a broader strategy.
We often recommend:
- Using confidentiality and non-disclosure agreements when sharing drafts
- Clearly identifying ownership in sponsor and investigator agreements
- Marking protocols with copyright notices where appropriate
- Avoiding unnecessary disclosure of narrative detail when summaries will suffice
These steps help reinforce your rights and reduce disputes about ownership or reuse.
When Copyright Disputes Arise in Clinical Research
Disputes often arise when a former partner, employee, or vendor uses protocol language in a later study. Courts look closely at whether the material copied reflects protected expression or unprotected scientific content.
If you are facing concerns about protocol reuse or infringement, early legal review can help clarify your position before the issue escalates.
Protecting Protocols Takes More Than One Tool
Clinical trial protocols sit at the intersection of science, regulation, and intellectual property law. While copyright can protect original written expression, it does not give you control over the underlying research methods. We help clients evaluate how copyright, contracts, and other IP tools work together so you can share protocols strategically while protecting what you have created.
If you have questions about ownership, reuse, or enforcement, contact Gearhart Law. We can help you assess your options and plan next steps.